Zaccardelli David's Form 4 filing
Verona Pharma plc (VRNA) · filed May 5, 2025
- Accession no.
- 0001104659-25-044530
- Filed
- May 5, 2025
- Trade date
- May 1-2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.31M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zaccardelli DavidCIK 0001627642 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Ordinary Shares | SSaleDisposed | −108,272 | $8.95 | −$969,034.4 | 14,268,904 | Direct | |
| May 1, 2025 | Ordinary Shares | MOption exerciseAcquired | +200,000 | – | – | 14,468,904 | Direct | |
| May 1, 2025 | Ordinary Shares | SSaleDisposed | −78,736 | $8.95 | −$704,687.2 | 14,390,168 | Direct | |
| May 2, 2025 | Ordinary Shares | SSaleDisposed | −400,000 | $9.09 | −$3,636,000 | 13,990,168 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2025 | Ordinary Shares | MOption exerciseDisposed | −200,000 | $0.00 | $0 | 1,000,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.